Amarin Corp Plc (AMRN)

[MedResCollab]

it's a long flight but the landing is coming soon. -KCSVEN

Well said. We couldn’t agree more. The current valuation is in our view “sky high,” and will eventually find its proper valuation much closer to here, “down on earth.”

Hopefully retail investors that are overweight AMRN have spoken with a registered investment advisor, and will not be too badly damaged financially if 1) the efficacy supplement is not approved, and/or 2) Amarin loses the ongoing patent infringement litigation in Jan 2020. Either of these will send the stock below $1. It’s unconformable to consider, but absolutely necessary to ask yourselves: how would that impact my family and me personally? I have been wrong before on outcomes I thought were nearly certain, what if I am wrong this time, too? An investment advisor can examine your personal situation and help you assess the risk more appropriately, and in an unbiased manner. Please do seek one out.